m6A-centered Drug Response Information
General Information of the Drug (ID: M6ADRUG0076)
| Name |
Ethyl ester form of meclofenamic acid
|
||||
|---|---|---|---|---|---|
| Synonyms |
Ethyl ester form of meclofenamic acid (MA), MA2
Click to Show/Hide
|
||||
| Status | Approved | [1] | |||
Full List of m6A Targets Related to This Drug
Meltrin-beta (ADAM19)
| In total 2 item(s) under this target gene | ||||
| Experiment 1 Reporting the m6A-centered Drug Response by This Target Gene | [2] | |||
| Response Summary | Knockdown of METTL3 or METTL14 induced changes in mRNA m6A enrichment and altered mRNA expression of genes (e.g., Meltrin-beta (ADAM19)) with critical biological functions in GSCs. Treatment with MA2, a chemical inhibitor of FTO, dramatically suppressed GSC-induced tumorigenesis and prolonged lifespan in GSC-grafted animals. | |||
| Responsed Disease | Glioblastoma | ICD-11: 2A00.00 | ||
| Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
| Target Regulation | Down regulation | |||
| Cell Process | Cells growth | |||
| Cells self-renewal | ||||
| Tumorigenesis | ||||
| MicroRNAs in cancer (hsa05206) | ||||
| In-vitro Model | GSC | Glioma | Epinephelus akaara | CVCL_M752 |
| In-vivo Model | 2 × 105 dissociated cells in 2 uL PBS were injected into the following site (anteroposterior [AP] +0.6 mm, mediolateral [ML] +1.6 mm, and dorsoventricular [DV] 2.6 mm) with a rate of 1 uL/min. | |||
| Experiment 2 Reporting the m6A-centered Drug Response by This Target Gene | [2] | |||
| Response Summary | Knockdown of METTL3 or METTL14 induced changes in mRNA m6A enrichment and altered mRNA expression of genes (e.g., Meltrin-beta (ADAM19)) with critical biological functions in GSCs. Treatment with MA2, a chemical inhibitor of FTO, dramatically suppressed GSC-induced tumorigenesis and prolonged lifespan in GSC-grafted animals. | |||
| Responsed Disease | Glioblastoma | ICD-11: 2A00.00 | ||
| Target Regulator | Methyltransferase-like 14 (METTL14) | WRITER | ||
| Target Regulation | Down regulation | |||
| Cell Process | Cells growth | |||
| Cells self-renewal | ||||
| Tumorigenesis | ||||
| MicroRNAs in cancer (hsa05206) | ||||
| In-vitro Model | GSC | Glioma | Epinephelus akaara | CVCL_M752 |
| In-vivo Model | 2 × 105 dissociated cells in 2 uL PBS were injected into the following site (anteroposterior [AP] +0.6 mm, mediolateral [ML] +1.6 mm, and dorsoventricular [DV] 2.6 mm) with a rate of 1 uL/min. | |||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Drug
| In total 1 item(s) under this drug | ||
| Crosstalk ID: M6ACROT03299 | ||
| m6A Regulator | Methyltransferase-like 3 (METTL3) | |
| m6A Target | Meltrin-beta (ADAM19) | |
| Epigenetic Regulator | Histone-lysine N-methyltransferase EZH2 (EZH2) | |
| Regulated Target | Histone H3 lysine 27 acetylation (H3K27ac) | |
| Crosstalk relationship | Histone modification → m6A | |
| Disease | Brain cancer | |
References